Periscope Capital’s Pfizer PFE Stock Holding History

Periscope Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-11,579	Closed	-$599K	–	1187
2022 Q1	$599K	Sell	11,579 -1,615	-12%	-$83.8K	0.02%	645
2021 Q4	$778K	Buy	+13,194	New	+$654K	0.02%	603

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Periscope Capital's PFE Position: Q2 2022 in Review

Periscope Capital sold out of Pfizer (PFE) in Q2 2022, closing a stake of 11,579 shares — an estimated $599K sold.

Periscope Capital first reported a position in PFE in Q4 2021 and held it in 2 quarters. The position peaked at $778K in Q4 2021. 3,157 funds tracked by Wall St. Rank hold PFE as of Q2 2022.

Periscope Capital reported no remaining Pfizer position as of Q2 2022 after selling out during the quarter.
Periscope Capital sold 11,579 Pfizer shares in Q2 2022, an estimated $599K.
Periscope Capital first reported a position in Pfizer in Q4 2021 and held it in 2 quarters.
Periscope Capital's Pfizer position peaked at $778K in Q4 2021.
3,157 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.

Based on Periscope Capital's 13F filing for Q2 2022, filed 15 Aug 2022.